Drug and Medication Analysis & Statistics, July 2014 (p10)

Talk to Amrita

+1 718 303 2019

Search inside this page

Publishers

All regions

You might be interested in: drug, vaccine, smoking cessation, more »

271-310 of about 4 600 reports

Purchase Reports From Reputable Market Research Publishers

Transcriptional Misregulation in Cancer Drug Pipeline Update 2014

Transcriptional Misregulation in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

There are today 222 companies plus partners developing 297 transcriptional misregulation targeting drugs in 1186 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated ...

  • Industries : Drug and Medication
HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2014

HIF-1 Signaling Pathway in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Cancer cells are characterized by rapid proliferation and require adaptive metabolic responses to allow continued biosynthesis and cell growth in the setting of decreased oxygen (O(2)) and nutrient availability. ...

  • Industries : Drug and Medication
Orphan Drugs in Oncology Drug Pipeline Update 2014

Orphan Drugs in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

This is a worldwide report on cancer drugs which have now or in the past received orphan drug status. This product will give you unique access not only to those cancer indications in which drugs are being ...

  • Industries : Drug and Medication
Conjugated Drugs in Oncology Drug Pipeline Update 2014

Conjugated Drugs in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Among conjugated drugs in oncology, antibody-drug conjugates (ADCs) are by far getting the most attention as a new drug class. Owing to improved technology and appropriate targeting, the clinical application ...

  • Industries : Drug and Medication
Mitochondrial Drugs in Oncology Drug Pipeline Update 2014

Mitochondrial Drugs in Oncology Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Focusing on mitochondria has recently become an intriguing target for cancer therapy. It is well known that mitochondrial activity in tumor cells is suppressed and exploiting the differences in mitochondrial ...

  • Industries : Drug and Medication
Breast Cancer Drug Pathway Analyzer 2014

Breast Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 532 targeted molecular therapies known to affect more than 253 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Colorectal Cancer Drug Pathway Analyzer 2014

Colorectal Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 375 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Lung Cancer Drug Pathway Analyzer 2014

Lung Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 487 targeted molecular therapies known to affect more than 254 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Prostate Cancer Drug Pathway Analyzer 2014

Prostate Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 386 targeted molecular therapies known to affect more than 244 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Hematological Cancers Drug Pathway Analyzer 2014

Hematological Cancers Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 672 targeted molecular therapies known to affect more than 256 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Renal Cancer Drug Pathway Analyzer 2014

Renal Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 221 targeted molecular therapies known to affect more than 240 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Ovarian Cancer Drug Pathway Analyzer 2014

Ovarian Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 320 targeted molecular therapies known to affect more than 250 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Pancreatic Cancer Drug Pathway Analyzer 2014

Pancreatic Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 294 targeted molecular therapies known to affect more than 246 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Brain Cancer Drug Pathway Analyzer 2014

Brain Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 213 targeted molecular therapies known to affect more than 237 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
Gastrointestinal Cancer Drug Pathway Analyzer 2014

Gastrointestinal Cancer Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 185 targeted molecular therapies known to affect more than 237 specific intracellular signaling pathways ...

  • Industries : Drug and Medication
MicroRNAs in Cancer Drug Pipeline Update 2014

MicroRNAs in Cancer Drug Pipeline Update 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

The hot entry of microRNA (miRNA) targeting drugs in oncology may come to revolutionize how we in the near future can launch a highly tumor-specific, multi-targeted attack with minimal toxicities eithe ...

  • Industries : Drug and Medication
Conjugated Drugs in Oncology: Drug Pathway Analyzer 2014

Conjugated Drugs in Oncology: Drug Pathway Analyzer 2014

  • $ 2 249
  • Industry report
  • July 2014
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 262 conjugated drugs known to affect more than 206 specific intracellular signaling pathways for the treatment ...

  • Industries : Drug and Medication
2014 Drugs of Abuse Testing in US Hospitals, Commercial Laboratories, Emergency Rooms and Ambulatory Care Centers

2014 Drugs of Abuse Testing in US Hospitals, Commercial Laboratories, Emergency Rooms and Ambulatory Care Centers

  • $ 1 750
  • Industry report
  • June 2014
  • by Venture Planning Group

This new 278-page report from Venture Planning Group provides a comprehensive analysis of the US drug of abuse testing market, including emerging tests, technologies, instrumentation, sales forecasts, ...

  • Industries : Drug and Medication
  • Countries : United States
Mucosis B.V. - Product Pipeline Review - 2014

Mucosis B.V. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

Mucosis B.V. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Mucosis B.V. - Product Pipeline Review - 2014', provides an overview of the Mucosis B.V.'s pharmaceutical research and ...

  • Industries : Drug and Medication
  • Countries : World
Venus Remedies Limited - Product Pipeline Review - 2014

Venus Remedies Limited - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

Venus Remedies Limited - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Venus Remedies Limited - Product Pipeline Review - 2014', provides an overview of the Venus Remedies Limited's ...

  • Industries : Drug and Medication
  • Countries : World
FluGen, Inc. - Product Pipeline Review - 2014

FluGen, Inc. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • July 2014
  • by Global Markets Direct

FluGen, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘FluGen, Inc. - Product Pipeline Review - 2014', provides an overview of the FluGen, Inc.'s pharmaceutical research and ...

  • Industries : Drug and Medication
  • Countries : World
LondonPharma Ltd - Product Pipeline Review - 2014

LondonPharma Ltd - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

LondonPharma Ltd - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘LondonPharma Ltd - Product Pipeline Review - 2014', provides an overview of the LondonPharma Ltd's pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : World
Drug and Medication in South Korea: HanAll Biopharma Co., Ltd. – Product Pipeline Review – H2 2011

Drug and Medication in South Korea: HanAll Biopharma Co., Ltd. – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

Ltd. - Product Pipeline Review - H2 2011” provides a detailed overview on the HanAll Biopharma Co., Ltd.’s research and development focus. The report includes data on current developmental pipeline, ...

  • Industries : Drug and Medication
  • Countries : World
Pharmaceutical Industry: Allergan, Inc. – Product Pipeline Review – H2 2011

Pharmaceutical Industry: Allergan, Inc. – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

- Product Pipeline Review - H2 2011” provides a detailed overview on the Allergan, Inc.’s research and development focus. The report includes data on current developmental pipeline, complete with latest ...

  • Industries : Drug and Medication
  • Countries : World
Teva Pharmaceutical Market Limited – Product Pipeline Review – H2 2011

Teva Pharmaceutical Market Limited – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...

  • Industries : Drug and Medication
  • Countries : World
Beijing Tiantan Biological Products Co., Ltd. - Product Pipeline Review - 2014

Beijing Tiantan Biological Products Co., Ltd. - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

Beijing Tiantan Biological Products Co., Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Beijing Tiantan Biological Products Co., Ltd. - Product Pipeline Review - 2014', provides ...

  • Industries : Drug and Medication
  • Countries : World
Drug and Medication in China: Novo Nordisk A/S – Product Pipeline Review – H2 2011

Drug and Medication in China: Novo Nordisk A/S – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • June 2014
  • by Global Markets Direct

The report includes data on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from ...

  • Industries : Drug and Medication
  • Countries : World
Drug and Medication in United States: POZEN Inc. – Product Pipeline Review – H2 2011

Drug and Medication in United States: POZEN Inc. – Product Pipeline Review – H2 2011

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

- Product Pipeline Review - H2 2011” provides a detailed overview on the POZEN Inc.’s research and development focus. The report includes data on current developmental pipeline, complete with latest ...

  • Industries : Drug and Medication
  • Countries : World
The Medicines Company - Product Pipeline Review - 2014

The Medicines Company - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

The Medicines Company - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘The Medicines Company - Product Pipeline Review - 2014', provides an overview of the The Medicines Company's pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : World
Wellstat Vaccines, LLC - Product Pipeline Review - 2014

Wellstat Vaccines, LLC - Product Pipeline Review - 2014

  • $ 1 500
  • Company report
  • May 2014
  • by Global Markets Direct

Wellstat Vaccines, LLC - Product Pipeline Review - 2014 Summary Global Markets Direct's, ‘Wellstat Vaccines, LLC - Product Pipeline Review - 2014', provides an overview of the Wellstat Vaccines, LLC's ...

  • Industries : Drug and Medication
  • Countries : World

85 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.